ReviewJournal of the American Heart Association2024
Tricuspid Regurgitation: A Review of Current Interventional Management.
Review in Journal of the American Heart Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.
- Unimodal to multimodal: a systematic review of predictive machine learning models for valvular heart diseases.Frontiers in cardiovascular medicine · 2026Pooled it
- Radial-Sectional CT for Tricuspid Valve Intervention Planning: A 4-Patient Clinical Case Series.JACC. Case reports · 2026Article
- Transcatheter Edge-to-Edge Repair for Tricuspid Regurgitation: Design and Rationale of the TEER-CHINA Trial.JACC. Asia · 2026Article
- Impaired Lung BCAA Metabolism Promotes Ferroptosis and Resultant Pulmonary Arterial Hypertension-Associated Hepatopathy.JACC. Basic to translational science · 2026Article
- Forgotten but Striking: Complete Tricuspid Valve Degeneration Unmasked by Lancisi's Sign.Cureus · 2026Article
- Behavior of mitral regurgitation after isolated tricuspid valve surgery: determinants and hemodynamic correlates.Journal of cardiothoracic surgery · 2026Article
- Comparative prognostic performance of risk scores for 12-month mortality and rehospitalization after transcatheter tricuspid valve intervention.Annals of cardiothoracic surgery · 2026Article
- Tricuspid Regurgitation: Pathophysiology, Risk Stratification, and Implications for Intervention.Journal of clinical medicine · 2026Review
- Off-Label Use of Septal Occluder Devices for Recurrent Tricuspid Regurgitation Following TEER.JACC. Case reports · 2026Article
- Chordae Rupture Alters Tricuspid Valve Leaflet Biomechanics.Cardiovascular engineering and technology · 2026Article
- Transcatheter edge-to-edge repair in symptomatic patients with severe tricuspid regurgitation and prior heart valve surgery.JTCVS open · 2026Article
- Congenital Tricuspid Valve Cleft Diagnosis Several Years after Pulmonary Valve Intervention.CASE (Philadelphia, Pa.) · 2026Article
- Phenotype-guided approach for device-based therapies in heart failure.Heart failure reviews · 2025Review
- Transcatheter tricuspid valve intervention versus optimal medical therapy alone for severe tricuspid regurgitation: an updated meta-analysis with reconstructed time-to-event data.International journal of cardiology. Heart & vasculature · 2025Article
- Impact of Transcatheter Tricuspid Valve Repair on Pre- and Post-Procedural Hospitalization Rates.CJC open · 2025Article
- Determinants of recovery from right ventricular dysfunction after transcatheter edge-to-edge tricuspid valve repair.Journal of cardiovascular medicine (Hagerstown, Md.) · 2025Article
- Patient Phenotypes Undergoing Tricuspid Transcatheter Edge-to-Edge Repair: Finding the Optimal Candidate.Journal of cardiovascular development and disease · 2025Review
- Emergent Transcatheter Tricuspid Edge-to-Edge Repair for Right Ventricular Shock From Tricuspid Regurgitation in Hypertrophic Cardiomyopathy.JACC. Case reports · 2025Article
- Carbohydrate Antigen-125: Endometrial Cancer or Heart Failure Biomarker?JACC. Case reports · 2025Article
- Long-Term Outcomes of Surgical and Transcatheter Interventions for Tricuspid Regurgitation: A Comprehensive Review.Journal of clinical medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tricuspid regurgitation is a common yet clinically complex problem, traditionally managed with diuretic therapy with no observable mortality benefit. Older studies on surgical intervention observed poor outcomes; however, this clinical reasoning predates current surgical approaches and novel transcatheter technology. The tricuspid apparatus is a complex structure that poses a technical challenge for surgeons and interventional cardiologists. Recent advances in surgical techniques and transcatheter therapy, particularly edge-to-edge repair devices, have demonstrated promising results for safety, reduction in tricuspid regurgitation, and improving quality of life. We review the clinical, imaging, and hemodynamic findings that characterize patients who should be considered for intervention, alongside the rapidly evolving approaches to interventional management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.